All In MedTech

Device Trial Radar · NCT03096236

Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD

Last checked: Nov 19, 2026Latest source record: Sep 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Mar 1, 2017

Primary completion

Mar 1, 2019

Study completion Sep 1, 2019

Sponsor

Lead sponsor
Kliniken Ludwigsburg-Bietigheim gGmbHAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 30, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Subepithelial gastric tumors are rare and usually detected incidentally. Most subepithelial tumors (SET) are benign but up to 13% of all lesions can be malignant. Histology after needle biopsy often brings no clear diagnosis in SET, so further strategy often remains unclear. Surveillance endoscopy can be associated with the risk of progression. Endoscopic resection usually is difficult, associated with high risk of complications and sometimes is not feasible. Surgical resection is also associated with a risk of complications and often refused by the patients. With the developement of the gFTRD-System gastric SET can now be resected endoscopically. The advantage of this technique is the complete resection and a full-thickness resections specimen for are definite histology.

Conditions

  • Feasibility, Complications

Interventions

  • EFTRDevice

    EFTR with the FTRD developed for gastric resection (gFTRD).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical successTime frame: 1 minute (immediate)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Klinikum Ludwigsburg

    Ludwigsburg, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.